Gyre Therapeutics (GYRE) Gross Profit (QoQ) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Gyre Therapeutics | 532.38 Mn | 518.25 Mn | 8.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 134.48% |
| Dec 31, 2025 | -184.02% |
| Sep 30, 2025 | 12.94% |
| Jun 30, 2025 | 21.05% |
| Mar 31, 2025 | -20.72% |
| Dec 31, 2024 | 8.83% |
| Sep 30, 2024 | 0.31% |
| Jun 30, 2024 | -6.64% |
| Mar 31, 2024 | 1.14% |
| Dec 31, 2023 | -16.07% |
| Sep 30, 2023 | 9.22% |
| Jun 30, 2023 | 18.68% |
| Mar 31, 2023 | -50.46% |
| Mar 31, 2022 | 71.43% |
| Dec 31, 2021 | -75.00% |
| Sep 30, 2021 | -14.29% |
| Jun 30, 2021 | 46.15% |
| Mar 31, 2021 | 98.60% |
| Dec 31, 2020 | -6,728.57% |
| Sep 30, 2020 | -99.14% |
| Jun 30, 2020 | -89.05% |